DOI:
10.1055/s-00000072
Seminars in Reproductive Medicine
LinksClose Window
References
Wakelee HA, Gettinger S, Engelman J. , et al.
A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer.
Cancer Chemother Pharmacol 2017;
79 (05) 923-932
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.